companydata.dkcompanydata.dk

Renovaro Biosciences Denmark ApS: Financial statements 2014

CVR: 26027322

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

Renovaro Biosciences Denmark ApS (CVR 26027322) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -8,457,022 and a net result of DKK -11,472,661 compared with DKK -10,561,248 the year before. Equity in the 2014 report amounted to DKK -20,951,214.

Gross Profit
DKK -8,457,022
Profit/Loss
DKK -11,472,661
Equity
DKK -20,951,214
Total Assets
DKK 2,898,015

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014--8.5M-11.5M-21M-
2013--5.6M-10.6M-9.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

Renovaro Biosciences Denmark ApS: The 2013 annual report is outJun 12, 2014

Renovaro Biosciences Denmark ApS has published its annual report for 2013. Gross profit came to DKK -5,558,844, and the net result was DKK -10,561,248.

Registered as owner of Renovaro Biosciences Denmark ApSFeb 12, 2014

As of February 12, 2014, is registered as an owner of Renovaro Biosciences Denmark ApS with an ownership share of 100%.

About Renovaro Biosciences Denmark ApS

Renovaro Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Enochian BioSciences Denmark ApS and DanDrit Biotech ApS. The management consists of David Hershel Weinstein. The company is owned by Lunai Bioworks Inc.. The company has 1 employee (2017). In 2026, the company reported a gross profit of DKK -4,478 and a net result of DKK -1,178,038 compared with DKK -4,629,959 the year before. Equity in the 2026 report amounted to DKK -91,933,986.

Source: annual report 2026, Danish Business Authority